Please try another search
Eastwood Bio-Medical Canada Inc. reported earnings results for the second quarter and six months ended April 30, 2024. For the second quarter, the company reported sales was CAD 0.127552 million compared to CAD 0.200203 million a year ago. Revenue was CAD 0.135198 million compared to CAD 0.219651 million a year ago. Net loss was CAD 0.130136 million compared to CAD 0.175832 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.For the six months, sales was CAD 0.320927 million compared to CAD 0.478166 million a year ago. Revenue was CAD 0.336199 million compared to CAD 0.551838 million a year ago. Net loss was CAD 0.184348 million compared to CAD 0.245065 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Revenue | 0.201 | 0.129 | 0.187 | 0.22 |
Gross Profit | 0.14 | 0.049 | 0.126 | 0.127 |
Operating Income | -0.063 | -0.148 | -0.111 | -0.147 |
Net Income | -0.054 | -0.184 | -0.117 | -0.176 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Assets | 0.396 | 0.489 | 0.483 | 0.513 |
Total Liabilities | 1.29 | 1.33 | 1.14 | 1.05 |
Total Equity | -0.895 | -0.841 | -0.657 | -0.539 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.001 | 0.003 | -0.003 | -0.006 |
Cash From Investing Activities | ||||
Cash From Financing Activities | -0.011 | -0.004 | -0.008 | 0.025 |
Net Change in Cash | -0.012 | -0.001 | -0.011 | 0.019 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review